Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.165 USD | +0.68% | -3.90% | -33.63% |
Apr. 09 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Apr. 09 | Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.63% | 137M | |
+24.47% | 47.9B | |
+46.56% | 41.42B | |
-2.81% | 40.7B | |
-6.20% | 28.92B | |
+9.46% | 25.55B | |
-20.77% | 19.27B | |
-0.59% | 12.15B | |
+28.13% | 12.14B | |
-0.34% | 11.99B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Oppenheimer Adjusts Syros Pharmaceuticals Price Target to $13 From $15, Maintains Outperform Rating